19:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
eridaemia (triglycerides >10-15 mmol/L). Lipid-lowering :@0.076190:0.266204:0.485130:0.266204:0.485130:0.250421:0.076190:0.250421:0.009827:0.004551:0.003024:0.010357:0.010326:0.009827:0.014182:0.003024:0.010326:0.005791:0.005579:0.005125:0.004551:0.003024:0.010175:0.003024:0.008104:0.009782:0.009827:0.004551:0.003024:0.010357:0.009827:0.005866:0.005791:0.009162:0.008376:0.008376:0.005020:0.008376:0.008376:0.005791:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.005579:0.004188:0.005775:0.006985:0.003024:0.010311:0.003024:0.010357:0.005020:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.004188
treatment is just one aspect of risk reduction and treat-:@0.076190:0.280740:0.480942:0.280740:0.480942:0.264957:0.076190:0.264957:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004717:0.003024:0.005866:0.004732:0.003069:0.009192:0.005866:0.005125:0.004732:0.009903:0.009223:0.009827:0.004732:0.010326:0.005866:0.010311:0.009827:0.009782:0.005125:0.004732:0.009903:0.004747:0.004732:0.004551:0.003024:0.005866:0.007590:0.004732:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004717:0.010326:0.009223:0.010357:0.004732:0.005125:0.004551:0.009827:0.010326:0.005125:0.005020
ment is not complete without advice on lifestyle modi-:@0.076190:0.295275:0.480972:0.295275:0.480972:0.279493:0.076190:0.279493:0.014182:0.009827:0.009223:0.005125:0.005156:0.003024:0.005866:0.005156:0.009223:0.009903:0.005125:0.005156:0.009782:0.009903:0.014182:0.010311:0.003024:0.009827:0.005125:0.009827:0.005156:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.005156:0.010326:0.010357:0.008376:0.003024:0.009782:0.009827:0.005171:0.009903:0.009223:0.005156:0.003024:0.003024:0.004747:0.009827:0.005866:0.005125:0.008104:0.003024:0.009827:0.005171:0.014182:0.009903:0.010357:0.003024:0.005020
fication (smoking cessation, diet, exercise) and control :@0.076190:0.309811:0.485115:0.309811:0.485115:0.294028:0.076190:0.294028:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005307:0.005579:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.005307:0.009782:0.009827:0.005866:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005307:0.010357:0.003024:0.009827:0.005125:0.004188:0.005307:0.009827:0.007257:0.009827:0.004551:0.009782:0.003024:0.005866:0.009827:0.005579:0.005307:0.010326:0.009223:0.010357:0.005307:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004188
of other risk factors, such as hypertension. Almost all pa-:@0.076190:0.324347:0.480942:0.324347:0.480942:0.308564:0.076190:0.308564:0.009903:0.004747:0.003991:0.009903:0.005125:0.009223:0.009827:0.004536:0.004007:0.004551:0.003024:0.005866:0.007590:0.004007:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.003991:0.005866:0.009192:0.009782:0.009223:0.004007:0.010326:0.005866:0.004007:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.003991:0.011188:0.003024:0.014182:0.009903:0.005866:0.005125:0.003991:0.010326:0.003024:0.003024:0.004007:0.010311:0.010326:0.005020
tients will require long-term therapy for optimal benefit.:@0.076190:0.338883:0.476074:0.338883:0.476074:0.323100:0.076190:0.323100:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.012564:0.003024:0.003024:0.003024:0.004188:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.004188:0.003024:0.009903:0.009223:0.010175:0.005020:0.005125:0.009827:0.004551:0.014182:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004747:0.009903:0.004551:0.004188:0.009903:0.010311:0.005125:0.003024:0.014182:0.010326:0.003024:0.004188:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188
Risk assessment always precedes the initiation of lipid-:@0.090478:0.353418:0.480942:0.353418:0.480942:0.337636:0.090478:0.337636:0.009177:0.003024:0.005866:0.007590:0.003961:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.014182:0.009827:0.009223:0.005125:0.003961:0.010326:0.003024:0.012564:0.010326:0.008104:0.005866:0.003961:0.010311:0.004551:0.009827:0.009782:0.009827:0.010357:0.009827:0.005866:0.003946:0.005125:0.009223:0.009827:0.003946:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.003946:0.009903:0.004747:0.003946:0.003024:0.003024:0.010311:0.003024:0.010357:0.005020
lowering treatment  and as  cardiovascular  risk in par-:@0.076190:0.367954:0.480942:0.367954:0.480942:0.352171:0.076190:0.352171:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.007166:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.002963:0.010326:0.009223:0.010357:0.007166:0.010326:0.005866:0.004188:0.002994:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.002994:0.004551:0.003024:0.005866:0.007590:0.007166:0.003024:0.009223:0.007166:0.010311:0.010326:0.004551:0.005020
ticular may be affected by many variables, there are :@0.076190:0.382490:0.485145:0.382490:0.485145:0.366707:0.076190:0.366707:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.006108:0.014182:0.010326:0.008104:0.006123:0.010311:0.009827:0.006108:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.009827:0.010357:0.006108:0.010311:0.008104:0.006123:0.014182:0.010326:0.009223:0.008104:0.006123:0.008376:0.010326:0.004551:0.003024:0.010326:0.010311:0.003024:0.009827:0.005866:0.004188:0.006123:0.005125:0.009223:0.009827:0.004551:0.009827:0.006108:0.010326:0.004551:0.009827:0.004188
no absolute lipid values at which treatment is indicated. :@0.076190:0.397025:0.485130:0.397025:0.485130:0.381243:0.076190:0.381243:0.009223:0.009903:0.003613:0.010326:0.010311:0.005866:0.009903:0.003024:0.009192:0.005125:0.009827:0.003629:0.003024:0.003024:0.010311:0.003024:0.010357:0.003629:0.008376:0.010326:0.003024:0.009192:0.009827:0.005866:0.003629:0.010326:0.005125:0.003629:0.012564:0.009223:0.003024:0.009782:0.009223:0.003629:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003613:0.003024:0.005866:0.003629:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004188:0.004188
patients with multiple risk factors, such as smoking, dia-:@0.076190:0.411561:0.480942:0.411561:0.480942:0.395778:0.076190:0.395778:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005125:0.012564:0.003024:0.005125:0.009223:0.005125:0.014182:0.009192:0.003024:0.005125:0.003024:0.010311:0.003024:0.009827:0.005125:0.004551:0.003024:0.005866:0.007590:0.005125:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.005110:0.005866:0.009192:0.009782:0.009223:0.005125:0.010326:0.005866:0.005125:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004188:0.005125:0.010357:0.003024:0.010326:0.005020
betes and hypertension, will need treatment at much :@0.076190:0.426097:0.485130:0.426097:0.485130:0.410314:0.076190:0.410314:0.010311:0.009827:0.005125:0.009827:0.005866:0.006214:0.010326:0.009223:0.010357:0.006214:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.006199:0.012564:0.003024:0.003024:0.003024:0.006229:0.009223:0.009827:0.009827:0.010357:0.006214:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.006199:0.010326:0.005125:0.006214:0.014182:0.009192:0.009782:0.009223:0.004188
lower lipid values than those in whom hypercholesterol-:@0.076190:0.440633:0.480957:0.440633:0.480957:0.424850:0.076190:0.424850:0.003024:0.009903:0.012564:0.009827:0.004551:0.004203:0.003024:0.003024:0.010311:0.003024:0.010357:0.004218:0.008376:0.010326:0.003024:0.009192:0.009827:0.005866:0.004218:0.005125:0.009223:0.010326:0.009223:0.004203:0.005125:0.009223:0.009903:0.005866:0.009827:0.004203:0.003024:0.009223:0.004218:0.012564:0.009223:0.009903:0.014182:0.004203:0.009223:0.008104:0.010311:0.009827:0.004551:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003054:0.005020
aemia is the only problem.:@0.076190:0.455168:0.270243:0.455168:0.270243:0.439386:0.076190:0.439386:0.010326:0.009827:0.014182:0.003024:0.010326:0.004188:0.003024:0.005866:0.004188:0.005125:0.009223:0.009827:0.004188:0.009903:0.009223:0.003024:0.008104:0.004188:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.004188
liPiD-mODifyinG DruGs:@0.076190:0.488435:0.296458:0.488435:0.296458:0.468270:0.076190:0.468270:0.008131:0.005174:0.010348:0.005174:0.012935:0.007761:0.016631:0.015522:0.012935:0.005174:0.008870:0.011457:0.005174:0.013674:0.015522:0.005174:0.012935:0.010718:0.011826:0.015522:0.009609
There are five major classes of lipid-modifying drugs that :@0.076190:0.504747:0.485130:0.504747:0.485130:0.488964:0.076190:0.488964:0.006441:0.009223:0.009827:0.004551:0.009827:0.003734:0.010326:0.004551:0.009827:0.003734:0.003681:0.003681:0.008376:0.009827:0.003750:0.014182:0.010326:0.003069:0.009903:0.004551:0.003734:0.009782:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.003750:0.009903:0.004747:0.003750:0.003024:0.003024:0.010311:0.003024:0.010357:0.005020:0.014182:0.009903:0.010357:0.003024:0.004747:0.008104:0.003024:0.009223:0.010175:0.003750:0.010357:0.004551:0.009192:0.010175:0.005866:0.003734:0.005125:0.009223:0.010326:0.005125:0.004188
are listed  in Table 1. Table 2 summarises  single-tablet :@0.076190:0.519283:0.485130:0.519283:0.485130:0.503500:0.076190:0.503500:0.010326:0.004551:0.009827:0.007121:0.003024:0.003024:0.005866:0.005125:0.009827:0.010357:0.004188:0.002948:0.003024:0.009223:0.007121:0.006441:0.010326:0.010311:0.003024:0.009827:0.007121:0.008376:0.004188:0.007121:0.006441:0.010326:0.010311:0.003024:0.009827:0.007121:0.008376:0.007121:0.005866:0.009192:0.014182:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.005866:0.004188:0.002948:0.005866:0.003024:0.009223:0.010175:0.003024:0.009827:0.005020:0.005125:0.010326:0.010311:0.003024:0.009827:0.005125:0.004188
combination therapies available in south Africa. There :@0.076190:0.533819:0.485145:0.533819:0.485145:0.518036:0.076190:0.518036:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005534:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.003024:0.009827:0.005866:0.005534:0.010326:0.008376:0.010326:0.003024:0.003024:0.010341:0.010311:0.003024:0.009827:0.005534:0.003024:0.009223:0.005534:0.007529:0.009903:0.009192:0.005125:0.009223:0.005518:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.005534:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188
are also two food supplements or “nutraceuticals” :@0.076190:0.548354:0.485145:0.548354:0.485145:0.532572:0.076190:0.532572:0.010326:0.004551:0.009827:0.010326:0.010326:0.003024:0.005866:0.009903:0.010326:0.005125:0.012564:0.009903:0.010326:0.004747:0.009903:0.009903:0.010357:0.010326:0.005866:0.009192:0.010311:0.010311:0.003024:0.009827:0.014182:0.009827:0.009223:0.005125:0.005866:0.010326:0.009903:0.004551:0.010326:0.007590:0.009223:0.009192:0.005125:0.004551:0.010326:0.009782:0.009827:0.009192:0.005125:0.003024:0.009782:0.010326:0.003024:0.005866:0.007318:0.004188
which influence lipid metabolism. Plant sterols or stanols :@0.076190:0.562890:0.485130:0.562890:0.485130:0.547107:0.076190:0.547107:0.012564:0.009223:0.003024:0.009782:0.009223:0.004173:0.003024:0.009223:0.003666:0.003666:0.009192:0.009827:0.009223:0.009782:0.009812:0.004173:0.003024:0.003024:0.010311:0.003024:0.010357:0.004188:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.014182:0.004188:0.004173:0.008950:0.003024:0.010326:0.009223:0.005125:0.004173:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.005866:0.004173:0.009903:0.004551:0.004173:0.005866:0.005125:0.010326:0.009223:0.009903:0.003024:0.005866:0.004188
can be added to foods such as margarine or yoghurt :@0.076190:0.577426:0.485145:0.577426:0.485145:0.561643:0.076190:0.561643:0.009782:0.010326:0.009223:0.005685:0.010311:0.009827:0.005685:0.010326:0.010357:0.010357:0.009827:0.010357:0.005685:0.005125:0.009903:0.005670:0.004747:0.009903:0.009903:0.010357:0.005866:0.005670:0.005866:0.009192:0.009782:0.009223:0.005685:0.010326:0.005866:0.005685:0.014182:0.010326:0.004551:0.010175:0.010326:0.004551:0.003024:0.009223:0.009827:0.005670:0.009903:0.004551:0.005670:0.008104:0.009903:0.010175:0.009223:0.009192:0.004551:0.005125:0.004188
and achieve modest  LDLC-lowering  in the  range  of :@0.076190:0.591961:0.485130:0.591961:0.485130:0.576179:0.076190:0.576179:0.010326:0.009223:0.010357:0.008467:0.010326:0.009782:0.009223:0.003024:0.009827:0.008376:0.009827:0.008467:0.014182:0.009903:0.010357:0.009827:0.005866:0.005125:0.004188:0.004264:0.006985:0.011249:0.006985:0.012292:0.005020:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.004188:0.004264:0.003024:0.009223:0.008467:0.005125:0.009223:0.009827:0.004188:0.004264:0.004551:0.010326:0.009223:0.010175:0.009827:0.004188:0.004264:0.009903:0.004747:0.004188
6-15%. Omega-3 fatty acids (fish oil supplements) have :@0.076190:0.606497:0.485145:0.606497:0.485145:0.590715:0.076190:0.590715:0.008376:0.005020:0.008376:0.008376:0.011717:0.004188:0.004974:0.013138:0.014182:0.009827:0.010175:0.010326:0.005020:0.008376:0.004974:0.004747:0.010326:0.005125:0.005125:0.008104:0.004974:0.010326:0.009782:0.003024:0.010357:0.005866:0.004974:0.005579:0.003681:0.003681:0.005866:0.009223:0.004974:0.009903:0.003024:0.003024:0.004974:0.005866:0.009192:0.010311:0.010311:0.003024:0.009827:0.014182:0.009827:0.009223:0.005125:0.005866:0.005579:0.004974:0.009223:0.010326:0.008376:0.009827:0.004188
a modest triglyceride-lowering effect  in mild hyper-:@0.076190:0.621033:0.480972:0.621033:0.480972:0.605250:0.076190:0.605250:0.010326:0.009434:0.014182:0.009903:0.010357:0.009827:0.005866:0.005125:0.009434:0.005125:0.004551:0.003024:0.010175:0.003024:0.008104:0.009782:0.009827:0.004551:0.003024:0.010357:0.009827:0.005020:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.009434:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.005231:0.003024:0.009223:0.009434:0.014182:0.003024:0.003024:0.010357:0.009434:0.009223:0.008104:0.010311:0.009827:0.004551:0.005020
triglyceridaemia and have been shown to reduce sud-:@0.076190:0.635569:0.480957:0.635569:0.480957:0.619786:0.076190:0.619786:0.005125:0.004551:0.003024:0.010175:0.003024:0.008104:0.009782:0.009827:0.004551:0.003024:0.010357:0.010326:0.009827:0.014182:0.003024:0.010326:0.004702:0.010326:0.009223:0.010357:0.004702:0.009223:0.010326:0.008376:0.009827:0.004702:0.010311:0.009827:0.009827:0.009223:0.004702:0.005866:0.009223:0.009903:0.012564:0.009223:0.004702:0.005125:0.009903:0.004702:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.004702:0.005866:0.009192:0.010357:0.005020
den cardiac death in high-risk individuals.:@0.076190:0.650104:0.379463:0.650104:0.379463:0.634322:0.076190:0.634322:0.010357:0.009827:0.009223:0.004188:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.009782:0.004188:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188:0.003024:0.009223:0.004188:0.009223:0.003024:0.010175:0.009223:0.005020:0.004551:0.003024:0.005866:0.007590:0.004188:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.005866:0.004188
The choice of a lipid-modifying agent for a particular :@0.090478:0.664640:0.485130:0.664640:0.485130:0.648857:0.090478:0.648857:0.006441:0.009223:0.009827:0.004566:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.004566:0.009903:0.004747:0.004566:0.010326:0.004566:0.003024:0.003024:0.010311:0.003024:0.010357:0.005020:0.014182:0.009903:0.010357:0.003024:0.004747:0.008104:0.003024:0.009223:0.010175:0.004581:0.010326:0.010175:0.009827:0.009223:0.005125:0.004566:0.004747:0.009903:0.004551:0.004566:0.010326:0.004566:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188
patient is based on the following criteria::@0.076190:0.679176:0.373143:0.679176:0.373143:0.663393:0.076190:0.663393:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188:0.003024:0.005866:0.004188:0.010311:0.010326:0.005866:0.009827:0.010357:0.004188:0.009903:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.004188:0.009782:0.004551:0.003024:0.005125:0.009827:0.004551:0.003024:0.010326:0.004188
•  Lipid phenotype: What is the primary lipid abnormal:@0.076190:0.693711:0.475907:0.693711:0.475907:0.677929:0.076190:0.677929:0.009162:0.004188:0.006804:0.006985:0.003024:0.010311:0.003024:0.010357:0.004430:0.010311:0.009223:0.009827:0.009223:0.009903:0.005110:0.008104:0.010311:0.009827:0.004188:0.004415:0.014514:0.009223:0.010326:0.005125:0.004415:0.003024:0.005866:0.004430:0.005125:0.009223:0.009827:0.004415:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004415:0.003024:0.003024:0.010311:0.003024:0.010357:0.004430:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024
-:@0.475907:0.693711:0.480927:0.693711:0.480927:0.677929:0.475907:0.677929:0.005020
ity? (See Table 3.):@0.096344:0.708247:0.224931:0.708247:0.224931:0.692465:0.096344:0.692465:0.003024:0.005125:0.008104:0.008935:0.004188:0.005579:0.007529:0.009827:0.009827:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.004188:0.005579
•  Therapeutic  goal:  cardiovascular  risk  reduction  or :@0.076190:0.722783:0.485130:0.722783:0.485130:0.707000:0.076190:0.707000:0.009162:0.004188:0.006804:0.006441:0.009223:0.009827:0.004551:0.010326:0.010311:0.009827:0.009192:0.005125:0.003024:0.009782:0.004188:0.004505:0.010175:0.009903:0.010326:0.003024:0.004188:0.004188:0.004505:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.004521:0.004551:0.003024:0.005866:0.007590:0.004188:0.004521:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004505:0.009903:0.004551:0.004188
prevention of pancreatitis?:@0.096344:0.737319:0.294207:0.737319:0.294207:0.721536:0.096344:0.721536:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.010311:0.010326:0.009223:0.009782:0.004551:0.009827:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.008935
•  Outcome data of drug for specified goal:@0.076190:0.751854:0.396669:0.751854:0.396669:0.736072:0.076190:0.736072:0.009162:0.004188:0.006804:0.013138:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.004188:0.010357:0.010326:0.005125:0.010326:0.004188:0.009903:0.004747:0.004188:0.010357:0.004551:0.009192:0.010175:0.004188:0.004747:0.009903:0.004551:0.004188:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009827:0.010357:0.004188:0.010175:0.009903:0.010326:0.003024
•  Risk of interaction with other drugs the patient is taking:@0.076190:0.766390:0.480972:0.766390:0.480972:0.750607:0.076190:0.750607:0.009011:0.004188:0.006955:0.009026:0.002873:0.005715:0.007439:0.003583:0.009752:0.004596:0.003583:0.002873:0.009071:0.004974:0.009676:0.004400:0.010175:0.009631:0.004974:0.002873:0.009752:0.009071:0.003583:0.012413:0.002873:0.004974:0.009071:0.003583:0.009752:0.004974:0.009071:0.009676:0.004400:0.003583:0.010205:0.004400:0.009041:0.010024:0.005715:0.003583:0.004974:0.009071:0.009676:0.003583:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.003583:0.002873:0.005715:0.003583:0.004974:0.010175:0.007439:0.002873:0.009071:0.010175
•  Side-effect profile of drug:@0.076190:0.780926:0.282626:0.780926:0.282626:0.765143:0.076190:0.765143:0.009162:0.004188:0.006804:0.007529:0.003024:0.010357:0.009827:0.005020:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004188:0.009903:0.004747:0.004188:0.010357:0.004551:0.009192:0.010175
•  Cost:@0.076190:0.795461:0.129530:0.795461:0.129530:0.779679:0.076190:0.779679:0.009162:0.004188:0.006804:0.012292:0.009903:0.005866:0.005125
statins:@0.076190:0.826915:0.127595:0.826915:0.127595:0.808583:0.076190:0.808583:0.008735:0.005040:0.011087:0.005040:0.004032:0.010079:0.007392
statins are the best-known and most widely prescribed :@0.076190:0.843621:0.485145:0.843621:0.485145:0.827838:0.076190:0.827838:0.007529:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004959:0.010326:0.004551:0.009827:0.004959:0.005125:0.009223:0.009827:0.004959:0.010311:0.009827:0.005866:0.005125:0.005020:0.007590:0.009223:0.009903:0.012564:0.009223:0.004959:0.010326:0.009223:0.010357:0.004959:0.014182:0.009903:0.005866:0.005125:0.004959:0.012564:0.003024:0.010357:0.009827:0.003024:0.008104:0.004974:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.004188
lipid-modifying  drugs.  Their  efficacy  and  safety  has :@0.076190:0.858157:0.485130:0.858157:0.485130:0.842374:0.076190:0.842374:0.003024:0.003024:0.010311:0.003024:0.010357:0.005020:0.014182:0.009903:0.010357:0.003024:0.004747:0.008104:0.003024:0.009223:0.010175:0.004188:0.005927:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188:0.004188:0.005912:0.006441:0.009223:0.009827:0.003024:0.004551:0.004188:0.005912:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.004188:0.005912:0.010326:0.009223:0.010357:0.004188:0.005912:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.004188:0.005912:0.009223:0.010326:0.005866:0.004188
been well documented in multiple large studies.  statins :@0.076190:0.872692:0.485140:0.872690:0.485140:0.856907:0.076190:0.856910:0.010311:0.009827:0.009827:0.009223:0.003855:0.012564:0.009827:0.003024:0.003024:0.003855:0.010357:0.009903:0.009782:0.009192:0.014182:0.009827:0.009223:0.005125:0.009827:0.010357:0.003840:0.003024:0.009223:0.003855:0.014182:0.009192:0.003024:0.005125:0.003024:0.010311:0.003024:0.009827:0.003855:0.003024:0.010326:0.004551:0.010175:0.009827:0.003855:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188:0.004863:0.003855:0.007529:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:-0.293569
1:@0.426018:0.867391:0.430876:0.867391:0.430876:0.858237:0.426018:0.858237:0.004858
primarily reduce LDLC and have been shown to reduce :@0.076185:0.887226:0.485125:0.887226:0.485125:0.871443:0.076185:0.871443:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.003024:0.003024:0.008104:0.003810:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.003795:0.006985:0.011249:0.006985:0.012292:0.003810:0.010326:0.009223:0.010357:0.003810:0.009223:0.010326:0.008376:0.009827:0.003810:0.010311:0.009827:0.009827:0.009223:0.003795:0.005866:0.009223:0.009903:0.012564:0.009223:0.003795:0.005125:0.009903:0.003795:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.004188
cardiovascular events in long-term studies. :@0.076185:0.901761:0.391477:0.901761:0.391477:0.885979:0.076185:0.885979:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188:0.003024:0.009223:0.004188:0.003024:0.009903:0.009223:0.010175:0.005020:0.005125:0.009827:0.004551:0.014182:0.004188:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188:0.004188
They are therefore the drugs of choice in hypercholes-:@0.090472:0.916297:0.480967:0.916297:0.480967:0.900515:0.090472:0.900515:0.006441:0.009223:0.009827:0.008104:0.003402:0.010326:0.004551:0.009827:0.003402:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.003387:0.005125:0.009223:0.009827:0.003402:0.010357:0.004551:0.009192:0.010175:0.005866:0.003402:0.009903:0.004747:0.003402:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.003402:0.003024:0.009223:0.003402:0.009223:0.008104:0.010311:0.009827:0.004551:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005020
terolaemic patients where cardiovascular risk reduction :@0.076185:0.930833:0.485140:0.930833:0.485140:0.915050:0.076185:0.915050:0.005125:0.009827:0.004551:0.009903:0.003024:0.010326:0.009827:0.014182:0.003024:0.009782:0.003795:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003795:0.012564:0.009223:0.009827:0.004551:0.009827:0.003795:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.003795:0.004551:0.003024:0.005866:0.007590:0.003795:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
is the primary goal of therapy. :@0.076185:0.945369:0.299161:0.945369:0.299161:0.929586:0.076185:0.929586:0.003024:0.005866:0.004188:0.005125:0.009223:0.009827:0.004188:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004188:0.010175:0.009903:0.010326:0.003024:0.004188:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004188
The  baseline LDLC and the  target  LDLC  determine :@0.533324:0.266208:0.927992:0.266208:0.927992:0.250425:0.533324:0.250425:0.006441:0.009223:0.009827:0.004188:0.003432:0.010311:0.010326:0.005866:0.009827:0.003024:0.003024:0.009223:0.009827:0.007635:0.006985:0.011249:0.006985:0.012292:0.007635:0.010326:0.009223:0.010357:0.007635:0.005125:0.009223:0.009827:0.004188:0.003432:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.004188:0.003432:0.006985:0.011249:0.006985:0.012292:0.004188:0.003432:0.010357:0.009827:0.005125:0.009827:0.004551:0.014182:0.003024:0.009223:0.009827:0.004188
the statin dosage. In south Africa, the current LDLC tar-:@0.519037:0.280870:0.923804:0.280870:0.923804:0.265088:0.519037:0.265088:0.005125:0.009223:0.009827:0.004536:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.004551:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.004188:0.004536:0.003417:0.009223:0.004551:0.007529:0.009903:0.009192:0.005125:0.009223:0.004536:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.004551:0.005125:0.009223:0.009827:0.004536:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.004536:0.006985:0.011249:0.006985:0.012292:0.004551:0.005125:0.010326:0.004551:0.005020
get is <1.8 mmol/L for those with clinically overt cardio:@0.519037:0.295533:0.918769:0.295533:0.918769:0.279750:0.519037:0.279750:0.010175:0.009827:0.005125:0.004838:0.003024:0.005866:0.004853:0.009162:0.008376:0.004188:0.008376:0.004853:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.004838:0.004747:0.009903:0.004551:0.004838:0.005125:0.009223:0.009903:0.005866:0.009827:0.004838:0.012564:0.003024:0.005125:0.009223:0.004838:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.004853:0.009903:0.008376:0.009827:0.004551:0.005125:0.004838:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903
-:@0.918769:0.295533:0.923788:0.295533:0.923788:0.279750:0.918769:0.279750:0.005020
vascular disease and most type II diabetics. In primary :@0.519037:0.310196:0.927992:0.310196:0.927992:0.294413:0.519037:0.294413:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005443:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005443:0.010326:0.009223:0.010357:0.005443:0.014182:0.009903:0.005866:0.005125:0.005428:0.005125:0.008104:0.010311:0.009827:0.005443:0.003417:0.003417:0.005443:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.005866:0.004188:0.005443:0.003417:0.009223:0.005443:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004188
prevention  patients with a 10-year risk of  15-30%, the :@0.519037:0.324859:0.927992:0.324859:0.927992:0.309076:0.519037:0.309076:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004188:0.002978:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.007182:0.012564:0.003024:0.005125:0.009223:0.007182:0.010326:0.007182:0.008376:0.008376:0.005020:0.008104:0.009827:0.010326:0.004551:0.007182:0.004551:0.003024:0.005866:0.007590:0.007182:0.009903:0.004747:0.004188:0.002978:0.008376:0.008376:0.005020:0.008376:0.008376:0.011717:0.004188:0.007182:0.005125:0.009223:0.009827:0.004188
target is <2.5 mmol/L, while the target is <3.0 mmol/L if :@0.519037:0.339521:0.927976:0.339521:0.927976:0.323739:0.519037:0.323739:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.005292:0.003024:0.005866:0.005292:0.009162:0.008376:0.004188:0.008376:0.005307:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.004188:0.005292:0.012564:0.009223:0.003024:0.003024:0.009827:0.005307:0.005125:0.009223:0.009827:0.005292:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.005292:0.003024:0.005866:0.005307:0.009162:0.008376:0.004188:0.008376:0.005277:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.005292:0.003024:0.004747:0.004188
the risk is less than 15%. statins have a non-linear dose-:@0.519037:0.354184:0.923788:0.354184:0.923788:0.338401:0.519037:0.338401:0.005125:0.009223:0.009827:0.005080:0.004551:0.003024:0.005866:0.007590:0.005095:0.003024:0.005866:0.005095:0.003024:0.009827:0.005866:0.005866:0.005095:0.005125:0.009223:0.010326:0.009223:0.005080:0.008376:0.008376:0.011717:0.004188:0.005095:0.007529:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005095:0.009223:0.010326:0.008376:0.009827:0.005095:0.010326:0.005095:0.009223:0.009903:0.009223:0.005020:0.003024:0.003024:0.009223:0.009827:0.010326:0.004551:0.005080:0.010357:0.009903:0.005866:0.009827:0.005020
response curve and doubling the dose of a statin only :@0.519037:0.368847:0.927976:0.368847:0.927976:0.353064:0.519037:0.353064:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.005382:0.009782:0.009192:0.004551:0.008376:0.009827:0.005382:0.010326:0.009223:0.010357:0.005397:0.010357:0.009903:0.009192:0.010311:0.003024:0.003024:0.009223:0.010175:0.005382:0.005125:0.009223:0.009827:0.005382:0.010357:0.009903:0.005866:0.009827:0.005382:0.009903:0.004747:0.005382:0.010326:0.005397:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005397:0.009903:0.009223:0.003024:0.008104:0.004188
lowers LDLC by a further 6%.:@0.519037:0.383509:0.723461:0.383509:0.723461:0.367727:0.519037:0.367727:0.003024:0.009903:0.012564:0.009827:0.004551:0.005866:0.004188:0.006985:0.011249:0.006985:0.012292:0.004188:0.010311:0.008104:0.004188:0.010326:0.004188:0.004747:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.004188:0.008376:0.011717:0.004188
The choice of statin is largely dictated by the required :@0.533324:0.398172:0.927946:0.398172:0.927946:0.382389:0.533324:0.382389:0.006138:0.008920:0.009525:0.005322:0.009480:0.008920:0.009601:0.002721:0.009480:0.009525:0.005322:0.009601:0.004445:0.005322:0.005564:0.004823:0.010024:0.004823:0.002721:0.008920:0.005322:0.002721:0.005564:0.005322:0.002721:0.010024:0.004248:0.009873:0.009525:0.002721:0.007801:0.005322:0.010054:0.002721:0.009480:0.004823:0.010024:0.004823:0.009525:0.010054:0.005322:0.010009:0.007801:0.005322:0.004823:0.008920:0.009525:0.005322:0.004248:0.009525:0.010009:0.008890:0.002721:0.004248:0.009525:0.010357:0.004188
reduction in LDLC, potential for drug interactions and cost.:@0.519037:0.412835:0.923804:0.412835:0.923804:0.397052:0.519037:0.397052:0.004248:0.009525:0.010054:0.008890:0.009480:0.004823:0.002721:0.009601:0.008920:0.003266:0.002721:0.008920:0.003266:0.006683:0.010946:0.006683:0.011989:0.003886:0.003266:0.010009:0.009601:0.004823:0.009525:0.008920:0.004823:0.002721:0.010024:0.002721:0.003266:0.004445:0.009601:0.004248:0.003266:0.010054:0.004248:0.008890:0.009873:0.003266:0.002721:0.008920:0.004823:0.009525:0.004248:0.010024:0.009480:0.004823:0.002721:0.009601:0.008920:0.005564:0.003266:0.010024:0.008920:0.010054:0.003266:0.009480:0.009601:0.005564:0.004823:0.004188
The drugs most likely to interact with statins by inhib-:@0.533324:0.427498:0.923773:0.427498:0.923773:0.411715:0.533324:0.411715:0.006441:0.009223:0.009827:0.005594:0.010357:0.004551:0.009192:0.010175:0.005866:0.005594:0.014182:0.009903:0.005866:0.005125:0.005594:0.003024:0.003024:0.007590:0.009827:0.003024:0.008104:0.005609:0.005125:0.009903:0.005594:0.003024:0.009223:0.005125:0.009827:0.004551:0.010326:0.009782:0.005125:0.005594:0.012564:0.003024:0.005125:0.009223:0.005609:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005609:0.010311:0.008104:0.005609:0.003024:0.009223:0.009223:0.003024:0.010311:0.005020
iting  their  hepatic metabolism, are  azole  antifungals, :@0.519037:0.442160:0.927976:0.442160:0.927976:0.426378:0.519037:0.426378:0.003024:0.005125:0.003024:0.009223:0.010175:0.004188:0.003508:0.005125:0.009223:0.009827:0.003024:0.004551:0.004188:0.003508:0.009223:0.009827:0.010311:0.010326:0.005125:0.003024:0.009782:0.007711:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.014182:0.004188:0.007711:0.010326:0.004551:0.009827:0.004188:0.003508:0.010326:0.006426:0.009903:0.003024:0.009827:0.004188:0.003508:0.010326:0.009223:0.005125:0.003024:0.004747:0.009192:0.009223:0.010175:0.010326:0.003024:0.005866:0.004188:0.004188
cyclosporine, macrolides, protease inhibitors and ami-:@0.519037:0.456823:0.923788:0.456823:0.923788:0.441040:0.519037:0.441040:0.009782:0.008104:0.009782:0.003024:0.009903:0.005866:0.010311:0.009903:0.004551:0.003024:0.009223:0.009827:0.004188:0.006153:0.014182:0.010326:0.009782:0.004551:0.009903:0.003024:0.003024:0.010357:0.009827:0.005866:0.004188:0.006153:0.010311:0.004551:0.009903:0.005125:0.009827:0.010326:0.005866:0.009827:0.006153:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.006153:0.010326:0.009223:0.010357:0.006153:0.010326:0.014182:0.003024:0.005020
odarone. Rosuvastatin and pravastatin are least affect-:@0.519037:0.471486:0.923804:0.471486:0.923804:0.455703:0.519037:0.455703:0.009903:0.010357:0.010326:0.004551:0.009903:0.009223:0.009827:0.004188:0.003991:0.009177:0.009903:0.005866:0.009192:0.008376:0.010326:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.004007:0.010326:0.009223:0.010357:0.004007:0.010311:0.004551:0.010326:0.008376:0.010326:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.004007:0.010326:0.004551:0.009827:0.004007:0.003024:0.009827:0.010326:0.005866:0.005125:0.004007:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.005020
ed by inhibition of cytochrome p450 enzymes. :@0.519037:0.486148:0.860168:0.486148:0.860168:0.470366:0.519037:0.470366:0.009827:0.010357:0.004188:0.010311:0.008104:0.004188:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.009782:0.008104:0.005125:0.009903:0.009782:0.009223:0.004551:0.009903:0.014182:0.009827:0.004188:0.010311:0.008376:0.008376:0.008376:0.004188:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.005866:0.004188:0.004188
There is no convincing evidence that any one statin :@0.533324:0.500811:0.927992:0.500811:0.927992:0.485029:0.533324:0.485029:0.006441:0.009223:0.009827:0.004551:0.009827:0.005685:0.003024:0.005866:0.005700:0.009223:0.009903:0.005685:0.009782:0.009903:0.009223:0.008376:0.003024:0.009223:0.009782:0.003024:0.009223:0.010175:0.005700:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.005685:0.005125:0.009223:0.010326:0.005125:0.005685:0.010326:0.009223:0.008104:0.005700:0.009903:0.009223:0.009827:0.005685:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.004188
offers superior risk reduction when compared to other :@0.519037:0.515474:0.927976:0.515474:0.927976:0.499691:0.519037:0.499691:0.009903:0.004747:0.004747:0.009827:0.004551:0.005866:0.006017:0.005866:0.009192:0.010311:0.009827:0.004551:0.003024:0.009903:0.004551:0.006017:0.004551:0.003024:0.005866:0.007590:0.006032:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.006017:0.012564:0.009223:0.009827:0.009223:0.006017:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.009827:0.010357:0.006017:0.005125:0.009903:0.006017:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188
statins, as long  as equivalent reductions  in  LDLC  are :@0.519037:0.530137:0.927992:0.530137:0.927992:0.514354:0.519037:0.514354:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188:0.007726:0.010326:0.005866:0.007726:0.003024:0.009903:0.009223:0.010175:0.004188:0.003523:0.010326:0.005866:0.007726:0.009827:0.010311:0.009192:0.003024:0.008376:0.010326:0.003024:0.009827:0.009223:0.005125:0.007726:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.003523:0.003024:0.009223:0.004188:0.003523:0.006985:0.011249:0.006985:0.012292:0.004188:0.003523:0.010326:0.004551:0.009827:0.004188
achieved. Table 4 provides further details on the statins :@0.519037:0.544799:0.927976:0.544799:0.927976:0.529017:0.519037:0.529017:0.010326:0.009782:0.009223:0.003024:0.009827:0.008376:0.009827:0.010357:0.004188:0.004581:0.006441:0.010326:0.010311:0.003024:0.009827:0.004581:0.008376:0.004596:0.010311:0.004551:0.009903:0.008376:0.003024:0.010357:0.009827:0.005866:0.004596:0.004747:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.004566:0.010357:0.009827:0.005125:0.010326:0.003024:0.003024:0.005866:0.004596:0.009903:0.009223:0.004581:0.005125:0.009223:0.009827:0.004581:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188
available in south Africa.:@0.519037:0.559462:0.701191:0.559462:0.701191:0.543679:0.519037:0.543679:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.003024:0.009223:0.004188:0.007529:0.009903:0.009192:0.005125:0.009223:0.004188:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188
The most frequent side effect of statins is muscle toxi-:@0.533324:0.574125:0.923788:0.574125:0.923788:0.558342:0.533324:0.558342:0.006441:0.009223:0.009827:0.004853:0.014182:0.009903:0.005866:0.005125:0.004853:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.004838:0.005866:0.003024:0.010357:0.009827:0.004853:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004853:0.009903:0.004747:0.004853:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004853:0.003024:0.005866:0.004853:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.004853:0.005125:0.009903:0.007257:0.003024:0.005020
city. patients may experience predominantly proximal :@0.519037:0.588787:0.927976:0.588787:0.927976:0.573005:0.519037:0.573005:0.009782:0.003024:0.005125:0.008104:0.004188:0.006244:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006244:0.014182:0.010326:0.008104:0.006259:0.009827:0.007257:0.010311:0.009827:0.004551:0.003024:0.009827:0.009223:0.009782:0.009827:0.006244:0.010311:0.004551:0.009827:0.010357:0.009903:0.014182:0.003024:0.009223:0.010326:0.009223:0.005125:0.003024:0.008104:0.006244:0.010311:0.004551:0.009903:0.007257:0.003024:0.014182:0.010326:0.003024:0.004188
muscle pain, with or without evidence of muscle break-:@0.519037:0.603450:0.923788:0.603450:0.923788:0.587668:0.519037:0.587668:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.004112:0.010311:0.010326:0.003024:0.009223:0.004188:0.004112:0.012564:0.003024:0.005125:0.009223:0.004112:0.009903:0.004551:0.004097:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.004097:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004112:0.009903:0.004747:0.004112:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.004112:0.010311:0.004551:0.009827:0.010326:0.007590:0.005020
down, as seen by elevation of the creatinine kinase. In :@0.519037:0.618113:0.927976:0.618113:0.927976:0.602330:0.519037:0.602330:0.010357:0.009903:0.012564:0.009223:0.004188:0.005004:0.010326:0.005866:0.005020:0.005866:0.009827:0.009827:0.009223:0.005004:0.010311:0.008104:0.005020:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.003024:0.009903:0.009223:0.005004:0.009903:0.004747:0.005004:0.005125:0.009223:0.009827:0.005004:0.009782:0.004551:0.009827:0.010326:0.005125:0.003024:0.009223:0.003024:0.009223:0.009827:0.005004:0.007590:0.003024:0.009223:0.010326:0.005866:0.009827:0.004188:0.005004:0.003417:0.009223:0.004188
the worst-case scenario, this may progress to rhabdo-:@0.519037:0.632776:0.923788:0.632776:0.923788:0.616993:0.519037:0.616993:0.005125:0.009223:0.009827:0.006199:0.012564:0.009903:0.004551:0.005866:0.005125:0.005020:0.009782:0.010326:0.005866:0.009827:0.006214:0.005866:0.009782:0.009827:0.009223:0.010326:0.004551:0.003024:0.009903:0.004188:0.006199:0.005125:0.009223:0.003024:0.005866:0.006214:0.014182:0.010326:0.008104:0.006214:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.006199:0.005125:0.009903:0.006199:0.004551:0.009223:0.010326:0.010311:0.010357:0.009903:0.005020
myolysis and renal failure due to myoglobinuria. :@0.519037:0.647438:0.871507:0.647438:0.871507:0.631656:0.519037:0.631656:0.014182:0.008104:0.009903:0.003024:0.008104:0.005866:0.003024:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.004551:0.009827:0.009223:0.010326:0.003024:0.004188:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.010357:0.009192:0.009827:0.004188:0.005125:0.009903:0.004188:0.014182:0.008104:0.009903:0.010175:0.003024:0.009903:0.010311:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.004188:0.004188
Muscle toxicity is dose-related and is seen more fre-:@0.533324:0.662101:0.923788:0.662101:0.923788:0.646318:0.533324:0.646318:0.013894:0.009192:0.005866:0.009782:0.003024:0.009827:0.006063:0.005125:0.009903:0.007257:0.003024:0.009782:0.003024:0.005125:0.008104:0.006063:0.003024:0.005866:0.006063:0.010357:0.009903:0.005866:0.009827:0.005020:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.006063:0.010326:0.009223:0.010357:0.006063:0.003024:0.005866:0.006063:0.005866:0.009827:0.009827:0.009223:0.006063:0.014182:0.009903:0.004551:0.009827:0.006048:0.004747:0.004551:0.009827:0.005020
quently in the elderly, those with renal failure, untreated :@0.519037:0.676764:0.927976:0.676764:0.927976:0.660981:0.519037:0.660981:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.003916:0.003024:0.009223:0.003931:0.005125:0.009223:0.009827:0.003916:0.009827:0.003024:0.010357:0.009827:0.004551:0.003024:0.008104:0.004188:0.003931:0.005125:0.009223:0.009903:0.005866:0.009827:0.003916:0.012564:0.003024:0.005125:0.009223:0.003916:0.004551:0.009827:0.009223:0.010326:0.003024:0.003916:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.003916:0.009192:0.009223:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.004188
hypothyroidism and when statins are co-prescribed with :@0.519037:0.691426:0.927961:0.691426:0.927961:0.675644:0.519037:0.675644:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.003462:0.010326:0.009223:0.010357:0.003462:0.012564:0.009223:0.009827:0.009223:0.003462:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.003477:0.010326:0.004551:0.009827:0.003462:0.009782:0.009903:0.005020:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.003462:0.012564:0.003024:0.005125:0.009223:0.004188
fibrates or drugs that inhibit their metabolism. Recently, :@0.519037:0.706089:0.928007:0.706089:0.928007:0.690307:0.519037:0.690307:0.003681:0.003681:0.010311:0.004551:0.010326:0.005125:0.009827:0.005866:0.004868:0.009903:0.004551:0.004868:0.010357:0.004551:0.009192:0.010175:0.005866:0.004868:0.005125:0.009223:0.010326:0.005125:0.004868:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.004868:0.005125:0.009223:0.009827:0.003024:0.004551:0.004868:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.014182:0.004188:0.004868:0.009177:0.009827:0.009782:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.004188
an increased risk of myopathy has been found with the :@0.519037:0.720752:0.927961:0.720752:0.927961:0.704969:0.519037:0.704969:0.010326:0.009223:0.004369:0.003024:0.009223:0.009782:0.004551:0.009812:0.010326:0.005866:0.009827:0.010357:0.004369:0.004551:0.003024:0.005866:0.007590:0.004369:0.009903:0.004747:0.004369:0.014182:0.008104:0.009903:0.010311:0.010326:0.005125:0.009223:0.008104:0.004369:0.009223:0.010326:0.005866:0.004369:0.010311:0.009827:0.009827:0.009223:0.004369:0.004747:0.009903:0.009192:0.009223:0.010357:0.004369:0.012564:0.003024:0.005125:0.009223:0.004369:0.005125:0.009223:0.009827:0.004188
80 mg dose of simvastatin and simvastatin should not be :@0.519037:0.735415:0.927976:0.735415:0.927976:0.719632:0.519037:0.719632:0.008376:0.008376:0.003372:0.014182:0.010175:0.003356:0.010357:0.009903:0.005866:0.009827:0.003356:0.009903:0.004747:0.003356:0.005866:0.003024:0.014182:0.008376:0.010326:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.003372:0.010326:0.009223:0.010357:0.003356:0.005866:0.003024:0.014182:0.008376:0.010326:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.003372:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003356:0.009223:0.009903:0.005125:0.003356:0.010311:0.009827:0.004188
uptitrated beyond 40 mg per day. patients who have :@0.519037:0.750077:0.927976:0.750077:0.927976:0.734295:0.519037:0.734295:0.009192:0.010311:0.005125:0.003024:0.005125:0.004551:0.010326:0.005125:0.009827:0.010357:0.006048:0.010311:0.009827:0.008104:0.009903:0.009223:0.010357:0.006048:0.008376:0.008376:0.006048:0.014182:0.010175:0.006048:0.010311:0.009827:0.004551:0.006048:0.010357:0.010326:0.008104:0.004188:0.006048:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006048:0.012564:0.009223:0.009903:0.006048:0.009223:0.010326:0.008376:0.009827:0.004188
taken simvastatin 80 mg per day for more than a year :@0.519037:0.764740:0.927992:0.764740:0.927992:0.748957:0.519037:0.748957:0.005125:0.010326:0.007590:0.009827:0.009223:0.005292:0.005866:0.003024:0.014182:0.008376:0.010326:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005307:0.008376:0.008376:0.005292:0.014182:0.010175:0.005292:0.010311:0.009827:0.004551:0.005292:0.010357:0.010326:0.008104:0.005292:0.004747:0.009903:0.004551:0.005292:0.014182:0.009903:0.004551:0.009827:0.005292:0.005125:0.009223:0.010326:0.009223:0.005292:0.010326:0.005292:0.008104:0.009827:0.010326:0.004551:0.004188
without muscle-related side  effects may  continue on :@0.519037:0.779403:0.928007:0.779403:0.928007:0.763620:0.519037:0.763620:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.007439:0.014182:0.009192:0.005866:0.009782:0.003024:0.009827:0.005020:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.007439:0.005866:0.003024:0.010357:0.009827:0.004188:0.003266:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.007439:0.014182:0.010326:0.008104:0.004188:0.003266:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.009827:0.007439:0.009903:0.009223:0.004188
this dose.:@0.519037:0.794066:0.586604:0.794066:0.586604:0.778283:0.519037:0.778283:0.005125:0.009223:0.003024:0.005866:0.004188:0.010357:0.009903:0.005866:0.009827:0.004188
2:@0.586610:0.788838:0.591468:0.788838:0.591468:0.779684:0.586610:0.779684:0.004858
ezetimibe:@0.519047:0.825872:0.596994:0.825872:0.596994:0.807541:0.519047:0.807541:0.008735:0.007728:0.010751:0.005040:0.004032:0.015791:0.004032:0.011087:0.010751
Ezetimibe is a cholesterol-absorption  inhibitor.  It  de-:@0.519047:0.842709:0.923814:0.842709:0.923814:0.826926:0.519047:0.826926:0.008104:0.006426:0.009827:0.005125:0.003024:0.014182:0.003024:0.010311:0.009827:0.009465:0.003024:0.005866:0.009465:0.010326:0.009465:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.005020:0.010326:0.010311:0.005866:0.009903:0.004551:0.010311:0.005125:0.003024:0.009903:0.009223:0.004188:0.005261:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.004188:0.005261:0.003417:0.005125:0.004188:0.005261:0.010357:0.009827:0.005020
creases LDLC by 15-25% as monotherapy. The maximal :@0.519047:0.857372:0.927972:0.857372:0.927972:0.841589:0.519047:0.841589:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.004808:0.006985:0.011249:0.006985:0.012292:0.004808:0.010311:0.008104:0.004808:0.008376:0.008376:0.005020:0.008376:0.008376:0.011717:0.004823:0.010326:0.005866:0.004808:0.014182:0.009903:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004793:0.006441:0.009223:0.009827:0.004808:0.014182:0.010326:0.007257:0.003024:0.014182:0.010326:0.003024:0.004188
benefit is seen at a dose of 10 mg/day and this is the :@0.519047:0.872034:0.928002:0.872034:0.928002:0.856252:0.519047:0.856252:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005851:0.003024:0.005866:0.005866:0.005866:0.009827:0.009827:0.009223:0.005866:0.010326:0.005125:0.005866:0.010326:0.005866:0.010357:0.009903:0.005866:0.009827:0.005866:0.009903:0.004747:0.005851:0.008376:0.008376:0.005866:0.014182:0.010175:0.006607:0.010357:0.010326:0.008104:0.005866:0.010326:0.009223:0.010357:0.005866:0.005125:0.009223:0.003024:0.005866:0.005866:0.003024:0.005866:0.005866:0.005125:0.009223:0.009827:0.004188
only marketed dose. Ezetimibe is  generally well  toler-:@0.519047:0.886697:0.923814:0.886697:0.923814:0.870914:0.519047:0.870914:0.009903:0.009223:0.003024:0.008104:0.007121:0.014182:0.010326:0.004551:0.007590:0.009827:0.005125:0.009827:0.010357:0.007121:0.010357:0.009903:0.005866:0.009827:0.004188:0.007121:0.008104:0.006426:0.009827:0.005125:0.003024:0.014182:0.003024:0.010311:0.009827:0.007121:0.003024:0.005866:0.004188:0.002948:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.003024:0.008104:0.007121:0.012564:0.009827:0.003024:0.003024:0.004188:0.002948:0.005125:0.009903:0.003024:0.009827:0.004551:0.005020
ated. The effect of ezetimibe is additive to that of statins :@0.519047:0.901360:0.928017:0.901360:0.928017:0.885577:0.519047:0.885577:0.010326:0.005125:0.009827:0.010357:0.004188:0.003583:0.006441:0.009223:0.009827:0.003583:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003583:0.009903:0.004747:0.003583:0.009827:0.006426:0.009827:0.005125:0.003024:0.014182:0.003024:0.010311:0.009827:0.003583:0.003024:0.005866:0.003583:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.008376:0.009827:0.003598:0.005125:0.009903:0.003583:0.005125:0.009223:0.010326:0.005125:0.003583:0.009903:0.004747:0.003583:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188
and its main use is as add-on treatment for patients who :@0.519047:0.916023:0.928002:0.916023:0.928002:0.900240:0.519047:0.900240:0.010326:0.009223:0.010357:0.003583:0.003024:0.005125:0.005866:0.003598:0.014182:0.010326:0.003024:0.009223:0.003598:0.009192:0.005866:0.009827:0.003583:0.003024:0.005866:0.003598:0.010326:0.005866:0.003598:0.010326:0.010357:0.010357:0.005020:0.009903:0.009223:0.003583:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003583:0.004747:0.009903:0.004551:0.003583:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003598:0.012564:0.009223:0.009903:0.004188
are not reaching LDLC targets at maximal doses of a :@0.519047:0.930685:0.927987:0.930685:0.927987:0.914903:0.519047:0.914903:0.010326:0.004551:0.009827:0.006290:0.009223:0.009903:0.005110:0.006290:0.004551:0.009827:0.010326:0.009782:0.009223:0.003024:0.009223:0.010175:0.006290:0.006985:0.011249:0.006985:0.012292:0.006290:0.005125:0.010326:0.004551:0.010175:0.009812:0.005125:0.005866:0.006290:0.010326:0.005125:0.006290:0.014182:0.010326:0.007257:0.003024:0.014182:0.010326:0.003024:0.006305:0.010357:0.009903:0.005866:0.009827:0.005866:0.006290:0.009903:0.004747:0.006290:0.010326:0.004188
potent statin or are statin-intolerant.:@0.519047:0.945348:0.780410:0.945348:0.780410:0.929565:0.519047:0.929565:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.004188:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.004188:0.009903:0.004551:0.004188:0.010326:0.004551:0.009827:0.004188:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005020:0.003024:0.009223:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.009223:0.005125:0.004188
table 4. statins currently marketed in south Africa:@0.077030:0.088780:0.437468:0.088780:0.437468:0.072281:0.077030:0.072281:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.007862:0.004536:0.009979:0.004536:0.003629:0.009071:0.006652:0.004233:0.009676:0.009071:0.004838:0.004838:0.009676:0.009071:0.004536:0.003629:0.008769:0.004233:0.014212:0.009979:0.004838:0.008769:0.009676:0.004536:0.009676:0.009979:0.004233:0.003629:0.009071:0.004233:0.007862:0.009676:0.009071:0.004536:0.009071:0.004233:0.011188:0.004233:0.004838:0.003629:0.009676:0.009979
statin:@0.082070:0.107628:0.113759:0.107628:0.113759:0.092963:0.082070:0.092963:0.006290:0.003629:0.007983:0.003629:0.002903:0.007257
starting dose:@0.250871:0.107628:0.326587:0.107628:0.326587:0.092963:0.250871:0.092963:0.006290:0.003629:0.007983:0.003870:0.003629:0.002903:0.007257:0.007983:0.003387:0.007983:0.007741:0.005322:0.007741
maximal dose:@0.388370:0.107628:0.471343:0.107628:0.471343:0.092963:0.388370:0.092963:0.010886:0.007983:0.006773:0.002903:0.011370:0.007983:0.002903:0.003387:0.007983:0.007741:0.005322:0.007741
lipid effects at starting dose:@0.630843:0.107628:0.793403:0.107628:0.793403:0.092963:0.630843:0.092963:0.005322:0.002903:0.007983:0.002903:0.007983:0.003387:0.007741:0.003387:0.003387:0.007741:0.007741:0.003629:0.005322:0.003387:0.007983:0.003629:0.003387:0.005322:0.003629:0.007983:0.003870:0.003629:0.002903:0.007257:0.007983:0.003387:0.007983:0.007741:0.005322:0.007741
lDlC:@0.556711:0.123022:0.585256:0.123022:0.585256:0.108357:0.556711:0.108357:0.005322:0.008467:0.005322:0.009434
% change:@0.541108:0.135851:0.600859:0.135851:0.600859:0.121185:0.541108:0.121185:0.010402:0.003387:0.007741:0.007257:0.007983:0.007257:0.007983:0.007741
HDlC:@0.696387:0.123022:0.727834:0.123022:0.727834:0.108357:0.696387:0.108357:0.008225:0.008467:0.005322:0.009434
% change:@0.682235:0.135851:0.741986:0.135851:0.741986:0.121185:0.682235:0.121185:0.010402:0.003387:0.007741:0.007257:0.007983:0.007257:0.007983:0.007741
tG:@0.845630:0.123022:0.860870:0.123022:0.860870:0.108357:0.845630:0.108357:0.005080:0.010160
% change:@0.823375:0.135851:0.883125:0.135851:0.883125:0.121185:0.823375:0.121185:0.010402:0.003387:0.007741:0.007257:0.007983:0.007257:0.007983:0.007741
Rosuvastatin :@0.082082:0.151244:0.158657:0.151244:0.158657:0.137215:0.082082:0.137215:0.007342:0.007922:0.004693:0.007354:0.006701:0.008261:0.004693:0.004100:0.008261:0.004100:0.002419:0.007378:0.003350
5 mg:@0.273973:0.151244:0.303509:0.151244:0.303509:0.137215:0.273973:0.137215:0.006701:0.003350:0.011345:0.008140
40 mg:@0.411750:0.151244:0.447987:0.151244:0.447987:0.137215:0.411750:0.137215:0.006701:0.006701:0.003350:0.011345:0.008140
-45:@0.562287:0.151244:0.579704:0.151244:0.579704:0.137215:0.562287:0.137215:0.004016:0.006701:0.006701
+13:@0.701757:0.151244:0.722488:0.151244:0.722488:0.137215:0.701757:0.137215:0.007330:0.006701:0.006701
-15:@0.844541:0.151244:0.861958:0.151244:0.861958:0.137215:0.844541:0.137215:0.004016:0.006701:0.006701
Atorvastatin :@0.082082:0.166638:0.155960:0.166638:0.155960:0.152609:0.082082:0.152609:0.008950:0.004100:0.007922:0.003641:0.006701:0.008261:0.004693:0.004100:0.008261:0.004100:0.002419:0.007378:0.003350
10 mg:@0.270623:0.166638:0.306860:0.166638:0.306860:0.152609:0.270623:0.152609:0.006701:0.006701:0.003350:0.011345:0.008140
80 mg:@0.411750:0.166638:0.447987:0.166638:0.447987:0.152609:0.411750:0.152609:0.006701:0.006701:0.003350:0.011345:0.008140
-38:@0.562287:0.166638:0.579704:0.166638:0.579704:0.152609:0.562287:0.152609:0.004016:0.006701:0.006701
+6:@0.705107:0.166638:0.719138:0.166638:0.719138:0.152609:0.705107:0.152609:0.007330:0.006701
-19:@0.844541:0.166638:0.861958:0.166638:0.861958:0.152609:0.844541:0.152609:0.004016:0.006701:0.006701
simvastatin :@0.082082:0.182032:0.151134:0.182032:0.151134:0.168003:0.082082:0.168003:0.006023:0.002419:0.011345:0.006701:0.008261:0.004693:0.004100:0.008261:0.004100:0.002419:0.007378:0.003350
10 mg:@0.270623:0.182032:0.306860:0.182032:0.306860:0.168003:0.270623:0.168003:0.006701:0.006701:0.003350:0.011345:0.008140
40 mg:@0.411750:0.182032:0.447987:0.182032:0.447987:0.168003:0.411750:0.168003:0.006701:0.006701:0.003350:0.011345:0.008140
-28:@0.562287:0.182032:0.579704:0.182032:0.579704:0.168003:0.562287:0.168003:0.004016:0.006701:0.006701
+8:@0.705107:0.182032:0.719138:0.182032:0.719138:0.168003:0.705107:0.168003:0.007330:0.006701
-19:@0.844541:0.182032:0.861958:0.182032:0.861958:0.168003:0.844541:0.168003:0.004016:0.006701:0.006701
pravastatin :@0.082082:0.197426:0.150408:0.197426:0.150408:0.183397:0.082082:0.183397:0.007160:0.003641:0.008261:0.006701:0.008261:0.004693:0.004100:0.008261:0.004100:0.002419:0.007378:0.003350
10 mg:@0.270623:0.197426:0.306860:0.197426:0.306860:0.183397:0.270623:0.183397:0.006701:0.006701:0.003350:0.011345:0.008140
80 mg:@0.411750:0.197426:0.447987:0.197426:0.447987:0.183397:0.411750:0.183397:0.006701:0.006701:0.003350:0.011345:0.008140
-19:@0.562287:0.197426:0.579704:0.197426:0.579704:0.183397:0.562287:0.183397:0.004016:0.006701:0.006701
+2:@0.705107:0.197426:0.719138:0.197426:0.719138:0.183397:0.705107:0.183397:0.007330:0.006701
-11:@0.844541:0.197426:0.861958:0.197426:0.861958:0.183397:0.844541:0.183397:0.004016:0.006701:0.006701
Fluvastatin :@0.082082:0.212820:0.146985:0.212820:0.146985:0.198791:0.082082:0.198791:0.005866:0.002419:0.007354:0.006701:0.008261:0.004693:0.004100:0.008261:0.004100:0.002419:0.007378:0.003350
20 mg:@0.270623:0.212820:0.306860:0.212820:0.306860:0.198791:0.270623:0.198791:0.006701:0.006701:0.003350:0.011345:0.008140
80 mg:@0.411750:0.212820:0.447987:0.212820:0.447987:0.198791:0.411750:0.198791:0.006701:0.006701:0.003350:0.011345:0.008140
-22:@0.562287:0.212820:0.579704:0.212820:0.579704:0.198791:0.562287:0.198791:0.004016:0.006701:0.006701
+3:@0.705107:0.212820:0.719138:0.212820:0.719138:0.198791:0.705107:0.198791:0.007330:0.006701
-12:@0.844541:0.212820:0.861958:0.212820:0.861958:0.198791:0.844541:0.198791:0.004016:0.006701:0.006701
Lovastatin :@0.082082:0.228214:0.144856:0.228214:0.144856:0.214185:0.082082:0.214185:0.005588:0.007922:0.006701:0.008261:0.004693:0.004100:0.008261:0.004100:0.002419:0.007378:0.003350
20 mg:@0.270623:0.228214:0.306860:0.228214:0.306860:0.214185:0.270623:0.214185:0.006701:0.006701:0.003350:0.011345:0.008140
80 mg:@0.411750:0.228214:0.447987:0.228214:0.447987:0.214185:0.411750:0.214185:0.006701:0.006701:0.003350:0.011345:0.008140
-29:@0.562287:0.228214:0.579704:0.228214:0.579704:0.214185:0.562287:0.214185:0.004016:0.006701:0.006701
+5:@0.705107:0.228214:0.719138:0.228214:0.719138:0.214185:0.705107:0.214185:0.007330:0.006701
-8:@0.847892:0.228214:0.858608:0.228214:0.858608:0.214185:0.847892:0.214185:0.004016:0.006701